Jay Bhogaita is Business Development Director within Aptar Pharma’s Pulmonary Category team, where he is responsible for developing pulmonary delivery strategies, especially relating to sustainability, which includes transition to newer, lower-GWP propellants and exploring alternative innovative technologies. In addition, he contributes to the service provision strategy for Nanopharm, an Aptar Pharma company, enabling faster route-to-market, particularly for generic medicines. With over 30 years’ experience in the medical devices industry, Mr Bhogaita has primarily focused on the inhalation sector.